Regeneron Pharmaceuticals shares owned by Anfield Capital Management
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Anfield Capital Management
from 13F filings
Historical chart of Anfield Capital Management investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Anfield Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Anfield Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $1.9k | 2 | 962.50 |
| 2022-12-31 | $165k | 228 | 721.49 |
| 2022-09-30 | $315k | 457 | 689.28 |
| 2022-06-30 | $261k | 441 | 591.84 |
| 2022-03-31 | $263k | 377 | 697.61 |
| 2021-12-31 | $114k | 181 | 629.83 |
| 2021-09-30 | $10k | 16 | 625.00 |
| 2021-06-30 | $10k | 18 | 555.56 |
More positions owned by Anfield Capital Management
View all positions for Anfield Capital Management